Shaheena Parween
Bern, BE, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Biased cytochrome P450-mediated metabolism via small-molecule ligands binding P450 oxidoreductase.
Journal: Nature communications
Published: September 10, 2020
Inhibition of placental CYP19A1 activity remains as a valid hypothesis for 46,XX virilization in P450 oxidoreductase deficiency.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: June 25, 2020
Metformin inhibits the activation of melanocortin receptors 2 and 3 in vitro: A possible mechanism for its anti-androgenic and weight balancing effects in vivo?
Journal: The Journal of steroid biochemistry and molecular biology
Published: December 11, 2019
Molecular Basis of CYP19A1 Deficiency in a 46,XX Patient With R550W Mutation in POR: Expanding the PORD Phenotype.
Journal: The Journal of clinical endocrinology and metabolism
Published: September 07, 2019
Bioactivity of Curcumin on the Cytochrome P450 Enzymes of the Steroidogenic Pathway.
Journal: International journal of molecular sciences
Published: September 05, 2019
Differential effects of variations in human P450 oxidoreductase on the aromatase activity of CYP19A1 polymorphisms R264C and R264H.
Journal: The Journal of steroid biochemistry and molecular biology
Published: June 09, 2019
Variability in human drug metabolizing cytochrome P450 CYP2C9, CYP2C19 and CYP3A5 activities caused by genetic variations in cytochrome P450 oxidoreductase.
Journal: Biochemical and biophysical research communications
Published: May 15, 2019
Variability in Loss of Multiple Enzyme Activities Due to the Human Genetic Variation P284T Located in the Flexible Hinge Region of NADPH Cytochrome P450 Oxidoreductase.
Journal: Frontiers in pharmacology
Published: May 10, 2019
CYP17A1 inhibitor abiraterone, an anti-prostate cancer drug, also inhibits the 21-hydroxylase activity of CYP21A2.
Journal: The Journal of steroid biochemistry and molecular biology
Published: July 11, 2017
Altered CYP19A1 and CYP3A4 Activities Due to Mutations A115V, T142A, Q153R and P284L in the Human P450 Oxidoreductase.
Journal: Frontiers in pharmacology
Published: October 02, 2016
P450 Oxidoreductase Deficiency: Loss of Activity Caused by Protein Instability From a Novel L374H Mutation.
Journal: The Journal of clinical endocrinology and metabolism
Published: September 08, 2016
P450 Oxidoreductase deficiency: Analysis of mutations and polymorphisms.
Journal: The Journal of steroid biochemistry and molecular biology
Published: March 18, 2016
Last Updated: 09/26/2026